Seoul, Republic of Korea July 24, 2022. In a landmark partnership, Avittia and Dot Inc are proud to announce their collaboration in Greece and Cyprus, aimed at revolutionizing accessibility for visually impaired individuals through the innovative DotPad technology. This groundbreaking alliance is set to pave the way for unprecedented advancements, offering hope and inspiration to millions around the globe.
The DotPad, a state-of-the-art tactile display, is more than just a technological marvel; it is a beacon of empowerment for the visually impaired community. By converting visual information into braille and tactile graphics, the DotPad opens new horizons of learning, communication, and independence. This collaboration between Avittia and Dot Inc signifies a commitment to inclusivity, ensuring that everyone, regardless of their visual abilities, can access the world’s vast array of information and opportunities.
At the heart of this partnership is a shared vision of creating a more inclusive society where technology bridges gap and brings people closer together. By leveraging Dot Inc’s expertise in cutting-edge technology and innovative approach to accessibility, this alliance is set to deliver transformative solutions that go beyond traditional boundaries. DotPad stands as a testament to what can be achieved when vision and technology converge for the greater good.
This collaboration is not just about technology; it is about hope. It is about envisioning a future where no one is left behind. DotPad’s ability to translate complex visual data into tactile formats means that visually impaired individuals can engage with content in ways previously deemed impossible. This empowerment extends to education, where students can now access detailed diagrams and illustrations, and to everyday life, where navigating complex environments becomes simpler and more intuitive.
In the words of the leaders of this partnership, “This is not just an agreement; it is a pledge to create a world where technology serves humanity in its truest sense. We are dedicated to pushing the boundaries of what is possible and bringing forth a future that is inclusive and accessible to all.”
The alliance between Avittia and Dot Inc represents a bold step towards a brighter, more inclusive future. It is a powerful reminder that when innovative minds come together with a shared purpose, the possibilities are limitless. This partnership is not just changing technology; it is changing lives, one DotPad at a time.
For media inquiries or further information, please contact:
Avittia Public Relations
Email: corporate@avittia.com
Landline: +30 2109822087
- We are excited to announce a groundbreaking strategic partnership between Avittia and the OFET Group, which encompasses leading healthcare companies including Unipharma and Intermed. This collaboration marks a significant milestone in advancing innovative medical device solutions across Greece and Cyprus.
- Enhanced Market Reach: Leveraging the combined networks and expertise of all partner organizations to maximize market penetration across Greece and Cyprus.
- Innovation Leadership: Bringing the latest medical device technologies to healthcare professionals and patients in the region.
- Comprehensive Support: Providing end-to-end customer support, from initial consultation through ongoing product assistance.
- Collaborative Excellence: Uniting the strengths of experienced teams to deliver superior healthcare solutions.
Partnership Overview
Through this strategic alliance, Avittia will work closely with the OFET Group to discover and propose cutting-edge medical devices and the OFET Group will launch and promote throughout the Greek and Cypriot markets. This partnership combines Avittia’s innovative approach with the established expertise and market presence of Unipharma and Intermed, creating a powerful synergy in the healthcare technology sector.
Comprehensive Support and Consumer Experience
Avittia’s team has undertaken full responsibility for after-sales product support, ensuring a seamless and holistic experience for end users. Working in close collaboration with the accomplished teams at Unipharma and Intermed, we are committed to delivering exceptional service and support throughout the entire customer journey.
Key Partnership Benefits
Looking Forward
This partnership represents our shared commitment to advancing healthcare technology and improving patient outcomes across the region. Together, we will continue to identify, develop, and deliver innovative medical devices that meet the evolving needs of healthcare providers and patients.
We look forward to the exciting opportunities this collaboration will bring and the positive impact it will have on healthcare delivery in Greece and Cyprus.
About OFET Group: O.F.E.T., the Tsetis Group of Pharmaceutical Companies, comprises two complimentary, dynamic companies, UNI-PHARMA S.A. and INTERMED S.A. that share parallel objectives, specializing in the research, development, production, and distribution of pharmaceutical products, food supplements, and medical devices. UNI-PHARMA S.A. was founded in 1969, with the scope of producing innovative pharmaceutical products. Uni-Pharma researches, develops, manufactures and markets pharmaceuticals of the highest quality and effectiveness, covering all major therapeutic categories. INTERMED S.A. was founded in 1996. Intermed develops and manufactures high quality products covering all major health care categories (Oral, Dermocosmetic, Gyneocological, Pediatric, Nutritional etc).
OFET is known for its innovative formulations and has a strong international presence, exporting to over 60 countries. The group is also recognized for its commitment to sustainability and has received numerous awards for its environmental initiatives and corporate social responsibility.
About Avittia: Avittia is a health and lifestyle company providing cutting edge medical devices and connected healthcare solutions for remote monitoring.
Avittia team exclusively represents unique physiology-optimized medical wearable sensors and data services to enable a deeper and more clinical relationship between provider and user. The unique range of the products, improve the health and the lives of patients, athletes, elderly or people interested in wellness, at all stages of life and all unmet needs.
CAMPBELL, California – Avittia and VivaLnK are excited to announce a groundbreaking partnership that will revolutionize healthcare in Greece and Cyprus. This strategic alliance combines Avittia’s expertise in healthcare solutions with VivaLnK’s cutting-edge wearable technology to deliver innovative patient care and empower medical professionals.
Innovative Technology for a Brighter Future
Technology is the cornerstone of modern healthcare. VivaLnK’s state-of-the-art wearable medical devices provide continuous, real-time monitoring of a patient’s vital signs. This crucial data is seamlessly integrated with Avittia’s healthcare solutions, giving doctors and nurses the insights they need to make swift, informed decisions. For patients, this means proactive care, reduced hospital visits, and better health outcomes.
This partnership is more than just a business agreement; it’s a commitment to a future where advanced healthcare solutions are accessible to all. We are dedicated to pushing the boundaries of what’s possible, ensuring that every heartbeat and every breath is protected.
Empowering Healthcare Professionals
The VivaLnK devices are designed for user-friendliness, allowing them to be easily integrated into existing workflows. This means less time on training and more time on patient care. By detecting potential issues before they become critical, this technology allows for proactive intervention, which not only improves patient outcomes but also makes healthcare delivery more efficient and cost-effective.
Key benefits for medical professionals include:
- Real-time patient monitoring
- Seamless data integration
- Enhanced diagnostic capabilities
- Improved workflow efficiency
Improving Quality of Life for Patients
VivaLnK’s comfortable, continuous monitoring provides patients with peace of mind. For those with chronic conditions, this technology can significantly improve their quality of life by reducing the need for frequent hospital visits and empowering them to manage their health effectively from home. This represents a new standard of proactive, patient-centered care focused on long-term health.
A Legacy of Innovation and Compassion
Avttia has always been committed to providing innovative healthcare solutions that improve lives. Our partnership with VivaLnK is a testament to that mission. By combining our strengths, we are not only transforming healthcare but also creating a legacy of excellence and compassion.
We invite you to join us on this journey as we work towards a future where advanced healthcare is within everyone’s reach. Together, we are making healthcare better, one innovation at a time.
Media Inquiries
Avittia Public Relations
Email: corporate@avittia.com
Landline: +30 210 98 22087